Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.

Ann Thorac Surg

Department of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, California 94143, USA.

Published: December 2003

Hemorrhage, refractory to aggressive conventional therapy, at a rate of 16 L/hr following separation from cardiopulmonary bypass for aortic arch repair, was controlled with a dose of 90 microg/kg of recombinant factor VIIa, repeated once after 2 hours.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-4975(03)01052-xDOI Listing

Publication Analysis

Top Keywords

recombinant factor
8
factor viia
8
aortic arch
8
arch repair
8
viia rescue
4
rescue treatment
4
treatment intractable
4
intractable bleeding
4
bleeding repeat
4
repeat aortic
4

Similar Publications

Introduction: We sought to explore the variability of antibody responses to multiple vaccines during early life in individual children, assess the trajectory of each child longitudinally, determine the associations of demographic variables and antibiotic exposures with vaccine-induced immunity, and link vaccine responsiveness to infection proneness.

Methods: In 357 prospectively-recruited children, age six through 36 months, antibody levels to 13 routine vaccine antigens were measured in sera at multiple time points and normalized to their respective protective thresholds to categorize children into four groups: very low, low, normal, and high vaccine responder. Demographic variables and frequency of antibiotic exposure data were collected.

View Article and Find Full Text PDF

Background: N6-methyladenosine (m6A) is one of the most conserved internal RNA modifications, which has been implicated in many biological processes, such as apoptosis and proliferation. Wilms tumor 1-associating protein (WTAP), as a key component of m6A methylation, is a nuclear protein that has been associated with the regulation of proliferation and apoptosis. Rheumatoid arthritis (RA), a systemic, infiltrating autoimmune disease, is characterized by synovial hyperplasia.

View Article and Find Full Text PDF

Background/objectives: Acute myeloid leukemia (AML) is an aggressive neoplasm. Although most patients respond to induction therapy, they commonly relapse due to recurrent disease in the bone marrow microenvironment (BMME). So, the disruption of the BMME, releasing tumor cells into the peripheral circulation, has therapeutic potential.

View Article and Find Full Text PDF

Ovarian aging significantly impacts female fertility, with mitochondrial dysfunction emerging as a key factor. This study investigated the effects of recombinant follicle-stimulating hormone (FSH) and luteinizing hormone (LH) on mitochondrial function and metabolism in aging female reproductive cells. Human granulosa cells (HGL5) were treated with FSH/LH or not.

View Article and Find Full Text PDF

Computational Study of Chalcogenide-Based Perovskite Solar Cell Using SCAPS-1D Numerical Simulator.

Materials (Basel)

January 2025

Fort Hare Institute of Technology, University of Fort Hare, Private Bag X1314, Alice 5700, Eastern Cape, South Africa.

Perovskite solar cells (PSCs) are regarded as extremely efficient and have significant potential for upcoming photovoltaic technologies due to their excellent optoelectronic properties. However, a few obstacles, which include the instability and high costs of production of lead-based PSCs, hinder their commercialization. In this study, the performance of a solar cell with a configuration of FTO/CdS/BaZrS/HTL/Ir was optimized by varying the thickness of the perovskite layer, the hole transport layer, the temperature, the electron transport layer (ETL)'s defect density, the absorber defect density, the energy band, and the work function for back contact.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!